DR. MEHRI SONGHORIAN MD NPI 1407838766

NPI Details

DR. Mehri Songhorian, MD is a neuromusculoskeletal medicine omm in Elmhurst, NY with 47 years of experience. The provider is the Neuromusculoskeletal Medicine and Osteopathic Manipulative Medicine physician directs special attention to the neuromusculoskeletal system and its interaction with other body systems. Neuromusculoskeletal Medicine and Osteopathic Manipulative Medicine encompasses increased knowledge and understanding of osteopathic principles and practice and heightened technical skills of osteopathic manipulative medicine, and integrates each of these into the management of pediatric, adolescent, adult, and geriatric patients. DR. Mehri Songhorian, MD NPI is 1407838766. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

59 10 JUNCTION BOULEVARD
ELMHURST, NY
ZIP 11373
Phone: (718) 760-4221
Fax: (718) 592-3844

The NPI 1407838766 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency (HCPCS:M0223)
• Insertion of needle into vein (3 years or older) (HCPCS:36410)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency (HCPCS:M0248)
• Follow-up nursing facility visit per day, typically 10 minutes (HCPCS:99307)
• Injection, bebtelovimab, 175 mg (HCPCS:Q0222)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital duri (HCPCS:M0244)
• Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergen (HCPCS:M0246)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Measurement of brain wave activity (eeg), awake and drowsy (HCPCS:95816)
• Measurement of brain wave activity (eeg), 41-60 minutes (HCPCS:95812)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Assessment of and care planning for impaired thought processing, typically 50 minutes (HCPCS:99483)

The enumeration date for this NPI number is 11/14/2005 and was last updated on 4/16/2009.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.